As RSV evolves, a two‑pronged antibody cocktail aims to stay ahead
Scientists in China have developed a two-antibody cocktail to treat respiratory syncytial virus, or RSV, that in laboratory studies prevented the virus from developing drug resistance—a persistent problem with current therapies ...









